NOVEL MARKERS FOR CARDIOPATHIES

Details for Australian Patent Application No. 2002351934 (hide)

Owner MAX-PLANCK-GESELLSCHAFT

Inventors PERROT, Andreas; SALEH, Aydah; RUIZ, Patricia; GRZWESKOWIAK, Rafael; DRUNGOWSKI, Mario; WITT, Henning; OSTERZIEL, Karl, J.

Pub. Number AU-A-2002351934

PCT Number PCT/EP02/12522

PCT Pub. Number WO2003/040407

Priority 01 126 800.0 09.11.01 EP

Filing date 8 November 2002

Wipo publication date 19 May 2003

International Classifications

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 01 126 800.0 09.11.01 EP

24 July 2003 Application Open to Public Inspection

  Published as AU-A-2002351934

29 July 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002351935-COMPOUNDS FOR THE DIAGNOSIS/ PREVENTION/TREATMENT OF ALZHEIMER'S DISEASE

2002351933-MEN PROTEIN, GST2, RAB-RP1, CSP, F-BOX PROTEIN LILINA/FBL7, ABC50, CORONIN, SEC61 ALPHA, OR VHAPPA1-1, OR HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS